Xofigo for Prostate Cancer

Xofigo for Prostate Cancer

The Food and Drug Administration has very recently approved a new pharmaceutical, Xofigo, for the treatment of late stage prostate cancer. The drug is a new hope for the treatment of a kind of cancer that affects more than 50% of men over 55 and over 90% of men over...
Kyprolis for Multiple Myeloma, an Overview

Kyprolis for Multiple Myeloma, an Overview

Kyprolis, generic carfilzomib, is a new treatment specifically approved for multiple myeloma (MM) cancer, but with potential applications to other cancers. It works as a proteasome inhibitor and is the latest medication of that class approved for MM. The Disease MM is...